Intimacy of Women With Cystic Fibrosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

211 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-19

Study Completion Date

2021-05-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The intimate life of patients with cystic fibrosis has not been the subject of specific research, it is even left behind in favor of respiratory, digestive or endocrinological dysfunctions endangering these patients. After 16 years of practice, it is significant that this subject is problematic, painful but difficult to tackle; No doubt just as much on the side of caregivers: this question has never found its way into team exchanges, it seems to be evaded doubtless difficult or too intimate to welcome. These disorders arise from the effects of the disease on the health of the mucous epithelial tissues also located in the genital area. These difficulties are more closely approached by the difficulties of procreation; PMA allows them to get around them, nevertheless making it possible to be a parent, with the residual frustration of a satisfactory sex life: a deaf "addition", adding to many care constraints.

It is therefore in terms of sexual health and quality of sexual life that it is desirable to shed light on this aspect of cystic fibrosis in women.

Bibliographic research confirms this approach: this subject is not explored, the rare publications concern the vulnerability of the cervix or the difficulty on both sides of tackling this subject.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gynecological Health Improvement of Adult Women With Cystic Fibrosis

NCT03892304

Cystic Fibrosis

COMPLETED

Contraceptive Practices and Cervical Screening in Women With Cystic Fibrosis

NCT02847208

Cystic Fibrosis

COMPLETED

Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis

NCT06507956

Cystic Fibrosis

RECRUITING

Improving Therapeutic Adherence With a Co-constructed Program Involving Both Patients and Health Care Professionals

NCT03226795

Cystic Fibrosis

UNKNOWN NA

Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy Treatment

NCT06327802

Cystic Fibrosis

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mucoviscidosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women with cystic fibrosis

Intimate quality of life questionnaire

Intervention Type OTHER

Preparation of an intimate quality of life questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intimate quality of life questionnaire

Preparation of an intimate quality of life questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major women with cystic fibrosis
* Tracked in the various CRCMs in France,
* Having or having had sexual intercourse,
* Having previously been informed of the aims and confidentiality of this research and not having opposed their participation.

Exclusion Criteria

* Major women with cystic fibrosis whose state of health (acute episode of their disease or worsening phase) does not lend itself to such a collection
* Adult women with cystic fibrosis who are unable to receive the information and make a non-objection

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No